Barclays’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Barclays’s Portfolio RCPI Stock Details RCPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-59	Closed	–	–	7247
2015 Q3	$0	Hold	59	–	–	﹤0.01%	7435
2015 Q2	$0	Sell	59 -644	-92%	-$1.53K	﹤0.01%	7493
2015 Q1	$0	Sell	703 -968	-58%	-$3.81K	﹤0.01%	7468
2014 Q4	$0	Sell	1,671 -412	-20%	-$2.17K	﹤0.01%	7906
2014 Q3	$0	Sell	2,083 -3,501	-63%	-$34.6K	﹤0.01%	8014
2014 Q2	$0	Buy	+5,584	New	+$96.9K	﹤0.01%	8003

Other funds holding RCPI

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

KCM

Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return

WealthPLAN Partners Omaha, Nebraska $523M AUM 23.92% 1-Year Est. Return

IWMPD

Integrated Wealth Management (Palm Desert) Palm Desert, California $299M AUM 12.85% 1-Year Est. Return

Barclays's RCPI Position: Q4 2015 in Review

Barclays sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q4 2015, closing a stake of 59 shares.

Barclays first reported a position in RCPI in Q2 2014 and held it in 6 quarters. The position peaked at $0 in Q3 2015. 9 funds tracked by Wall St. Rank hold RCPI as of Q4 2015.

Barclays reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
Barclays sold 59 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q4 2015.
Barclays first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 6 quarters.
Barclays's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $0 in Q3 2015.
9 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q4 2015.

Based on Barclays's 13F filing for Q4 2015, filed 12 Feb 2016.